Steroid-induced psychosis: Difference between revisions
(Created page with "==Background== ==Clinical Features== ==Differential Diagnosis== ==Evaluation== ===Workup=== ===Diagnosis=== ==Management== ==Disposition== ==See Also== ==External Links== ==References== <references/>") |
|||
| (18 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*~5% of patients on ≥40 mg daily of [[prednisone]] have psychiatric symptoms<ref>Acute adverse reactions to [[prednisone]] in relation to dosage. Clin Pharmacol Ther. 1972;13:694-698.</ref> | |||
**Incidence rises to just under 20% for patients receiving more ≥80 mg per day | |||
*Mechanism unproven but thought to be increased dopamine due to induction of tyrosin hydroxylase by corticosteroids<ref>J Pharm Technol. 2021 Apr; 37(2): 120–126. Published online 2020 Dec 2.</ref> | |||
==Clinical Features== | ==Clinical Features== | ||
*Time of onset variable | |||
**Median onset after 11.5-12.5 days<ref>Lewis DA, Smith RE. Steroid-Induced Psychiatric Syndromes. J Affect Disord. 1983;5(4):319-332.</ref><ref>Nishimura K, Harigai M, Omori M, Sato E, Hara M. Blood-Brain Barrier Damage as a Risk Factor for Corticosteroid-Induced Psychiatric Disorders in Systemic Lupus Erythematosus. Psychoneuroendocrinology. 2008;33(3):395-403.</ref> | |||
**Case reports of psychosis within one day after exposure | |||
*Wide range of possible psychiatric symptoms | |||
**[[Delusions]] or [[hallucinations]] | |||
**Euphoria | |||
**[[Mania]], [[depression]], [[anxiety]] | |||
**Severe cases may present with [[suicidal ideation]], violence, aggression | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{AMS DDX}} | |||
==Evaluation== | ==Evaluation== | ||
===Workup=== | ===Workup=== | ||
*Diagnosis of exclusion | |||
*DSM 5 diagnostic criteria | |||
**Must include hallucinations or delusions after steroid exposure<ref>American Psychiatric Association. Schizophrenia Spectrum and Other Psychotic Disorders: Substance/Medication-Induced Psychotic Disorder. DSM-5-TR. Published 2022.</ref> | |||
**Other causes cannot explain symptoms | |||
===Diagnosis=== | ===Diagnosis=== | ||
*Consider [[AMS]] workup | |||
==Management== | ==Management== | ||
*Cease offending agent or taper depending on clinical need for [[corticosteroids]] vs psychiatric complications | |||
**Onset of relief of symptoms vary widely, with some improving within 24 hours or as long as 8 weeks at the longest | |||
**Discontinuing immediately, as opposed to tapering, contributed to quicker resolution of symptoms | |||
*Antipsychotics mediate dopamine D2 receptor, correlating with possible mechanism of steroid induced psychosis | |||
**2nd generation [[antipsychotics]], low-moderate dosage - [[risperdone]], [[olanzapine]], [[quetiapine]]<ref>Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394:939-951.</ref> | |||
**Severe may require IM/IV doses | |||
*Consult psychiatry for duration of medication treatment | |||
==Disposition== | ==Disposition== | ||
*Admission for severe cases | |||
*Possible discharge for mild cases, consider short supply atypical [[antipsychotics]] and close follow up | |||
==See Also== | ==See Also== | ||
| Line 27: | Line 48: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Neurology]] | |||
Latest revision as of 22:55, 29 January 2025
Background
- ~5% of patients on ≥40 mg daily of prednisone have psychiatric symptoms[1]
- Incidence rises to just under 20% for patients receiving more ≥80 mg per day
- Mechanism unproven but thought to be increased dopamine due to induction of tyrosin hydroxylase by corticosteroids[2]
Clinical Features
- Time of onset variable
- Wide range of possible psychiatric symptoms
- Delusions or hallucinations
- Euphoria
- Mania, depression, anxiety
- Severe cases may present with suicidal ideation, violence, aggression
Differential Diagnosis
Altered mental status
Diffuse brain dysfunction
- Hypoxic encephalopathy
- Acute toxic-metabolic encephalopathy (Delirium)
- Hypoglycemia
- Hyperosmolar state (e.g., hyperglycemia)
- Electrolyte Abnormalities (hypernatremia or hyponatremia, hypercalcemia)
- Organ system failure
- Hepatic Encephalopathy
- Uremia/Renal Failure
- Endocrine (Addison's disease, Cushing syndrome, hypothyroidism, myxedema coma, thyroid storm)
- Hypoxia
- CO2 narcosis
- Hypertensive Encephalopathy
- Toxins
- TTP / Thrombotic thrombocytopenic purpura
- Alcohol withdrawal
- Drug reactions (NMS, Serotonin Syndrome)
- Environmental causes
- Deficiency state
- Wernicke encephalopathy
- Subacute Combined Degeneration of Spinal Cord (B12 deficiency)
- Vitamin D Deficiency
- Zinc Deficiency
- Sepsis
- Osmotic demyelination syndrome (central pontine myelinolysis)
- Limbic encephalitis
Primary CNS disease or trauma
- Direct CNS trauma
- Diffuse axonal injury
- Subdural/epidural hematoma
- Vascular disease
- SAH
- Stroke
- Hemispheric, brainstem
- CNS infections
- Neoplasms
- Paraneoplastic Limbic encephalitis
- Malignant Meningitis
- Pancreatic Insulinoma
- Seizures
- Nonconvulsive status epilepticus
- Postictal state
- Dementia
Psychiatric
Evaluation
Workup
- Diagnosis of exclusion
- DSM 5 diagnostic criteria
- Must include hallucinations or delusions after steroid exposure[5]
- Other causes cannot explain symptoms
Diagnosis
- Consider AMS workup
Management
- Cease offending agent or taper depending on clinical need for corticosteroids vs psychiatric complications
- Onset of relief of symptoms vary widely, with some improving within 24 hours or as long as 8 weeks at the longest
- Discontinuing immediately, as opposed to tapering, contributed to quicker resolution of symptoms
- Antipsychotics mediate dopamine D2 receptor, correlating with possible mechanism of steroid induced psychosis
- 2nd generation antipsychotics, low-moderate dosage - risperdone, olanzapine, quetiapine[6]
- Severe may require IM/IV doses
- Consult psychiatry for duration of medication treatment
Disposition
- Admission for severe cases
- Possible discharge for mild cases, consider short supply atypical antipsychotics and close follow up
See Also
External Links
References
- ↑ Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther. 1972;13:694-698.
- ↑ J Pharm Technol. 2021 Apr; 37(2): 120–126. Published online 2020 Dec 2.
- ↑ Lewis DA, Smith RE. Steroid-Induced Psychiatric Syndromes. J Affect Disord. 1983;5(4):319-332.
- ↑ Nishimura K, Harigai M, Omori M, Sato E, Hara M. Blood-Brain Barrier Damage as a Risk Factor for Corticosteroid-Induced Psychiatric Disorders in Systemic Lupus Erythematosus. Psychoneuroendocrinology. 2008;33(3):395-403.
- ↑ American Psychiatric Association. Schizophrenia Spectrum and Other Psychotic Disorders: Substance/Medication-Induced Psychotic Disorder. DSM-5-TR. Published 2022.
- ↑ Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394:939-951.
